Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke

Terminated

Phase 2 Results N/A

Main Contacts

Name Phone E-mail
Albert Assad, MD Study Director
Associate Director, Clinical Trial Disclosure Contact 1-888-260-1599 clinicaltrialdisclosure@celgene.com

Other Locations

Name City State Country Status
Chattanooga Center for Neurologic Research Chattanooga Tennessee United States Unknown_status_icon